Current studies demonstrated that in inflammatory bowel disease (IBD), SOCS3 acts on multiple cell types—including epithelial cells, macrophages, dendritic cells, neutrophils, and T cells—to repair mucosal damage and balance immune responses [26]. This evidence concerns the gene SOCS3 and inflammatory bowel disease.